Literature DB >> 3054554

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.

R J Dattwyler1, D J Volkman, B J Luft, J J Halperin, J Thomas, M G Golightly.   

Abstract

The diagnosis of Lyme disease often depends on the measurement of serum antibodies to Borrelia burgdorferi, the spirochete that causes this disorder. Although prompt treatment with antibiotics may abrogate the antibody response to the infection, symptoms persist in some patients. We studied 17 patients who had presented with acute Lyme disease and received prompt treatment with oral antibiotics, but in whom chronic Lyme disease subsequently developed. Although these patients had clinically active disease, none had diagnostic levels of antibodies to B. burgdorferi on either a standard enzyme-linked immunosorbent assay or immunofluorescence assay. On Western blot analysis, the level of immunoglobulin reactivity against B. burgdorferi in serum from these patients was no greater than that in serum from normal controls. The patients had a vigorous T-cell proliferative response to whole B. burgdorferi, with a mean ( +/- SEM) stimulation index of 17.8 +/- 3.3, similar to that (15.8 +/- 3.2) in 18 patients with chronic Lyme disease who had detectable antibodies. The T-cell response of both groups was greater than that of a control group of healthy subjects (3.1 +/- 0.5; P less than 0.001). We conclude that the presence of chronic Lyme disease cannot be excluded by the absence of antibodies against B. burgdorferi and that a specific T-cell blastogenic response to B. burgdorferi is evidence of infection in seronegative patients with clinical indications of chronic Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054554     DOI: 10.1056/NEJM198812013192203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  76 in total

1.  Diagnosis of Lyme borreliosis by a whole-blood gamma interferon assay for cell-mediated immune responses.

Authors:  V K Sikand; J S Rothel; R M Martin
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

3.  A 49-year-old man with aseptic meningitis and multiple cranial neuropathies.

Authors:  J C Mazziotta; H Itabashi; C Orfuss; A Charles; R Collins
Journal:  West J Med       Date:  1991-03

4.  Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi.

Authors:  P A Rosa; D Hogan; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

5.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

6.  Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.

Authors:  R C Johnson; C B Kodner; P J Jurkovich; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 7.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

Review 8.  Lyme disease.

Authors:  D J Spalton
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

9.  Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation.

Authors:  M S de Souza; A L Smith; D S Beck; L J Kim; G M Hansen; S W Barthold
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.

Authors:  A Krause; G R Burmester; A Rensing; C Schoerner; U E Schaible; M M Simon; P Herzer; M D Kramer; R Wallich
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.